PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Novo Integrated Sciences, Inc. (NVOS)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US67011T2015

CUSIP

67011T201

Sector

Healthcare

IPO Date

Sep 22, 2017

Highlights

Market Cap

$1.09M

EPS (TTM)

-$1.33

Total Revenue (TTM)

$6.32M

Gross Profit (TTM)

$2.22M

EBITDA (TTM)

-$11.02M

Year Range

$0.03 - $1.41

Short %

1.45%

Short Ratio

1.13

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
NVOS vs. SNGX NVOS vs. MSFT NVOS vs. JBL
Popular comparisons:
NVOS vs. SNGX NVOS vs. MSFT NVOS vs. JBL

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Novo Integrated Sciences, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-86.67%
9.05%
NVOS (Novo Integrated Sciences, Inc.)
Benchmark (^GSPC)

Returns By Period

Novo Integrated Sciences, Inc. had a return of 6.17% year-to-date (YTD) and -92.40% in the last 12 months.


NVOS

YTD

6.17%

1M

-30.16%

6M

-85.84%

1Y

-92.40%

5Y*

-74.13%

10Y*

N/A

^GSPC (Benchmark)

YTD

4.46%

1M

2.46%

6M

9.31%

1Y

23.49%

5Y*

13.03%

10Y*

11.31%

*Annualized

Monthly Returns

The table below presents the monthly returns of NVOS, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202531.79%6.17%
2024-9.42%-15.17%-22.78%26.66%70.15%-28.57%-14.45%-50.95%-10.71%-34.41%-76.07%17.69%-93.68%
2023-37.94%1.52%-3.08%-2.28%10.00%12.20%-28.90%32.95%113.00%-13.18%-53.65%-31.58%-59.17%
2022-7.86%7.75%66.19%-0.87%-10.48%-8.78%-8.56%-2.63%-36.94%-74.76%-5.92%-19.33%-85.64%
2021102.38%-38.71%-32.82%-24.86%-15.59%13.06%-25.10%-3.19%1.10%-6.52%-16.28%-2.78%-66.67%
202022.22%-39.09%-16.72%-46.24%-4.00%18.13%99.88%17.65%-5.00%-5.26%5.56%10.53%-6.67%
2019-7.50%-13.51%-3.12%-16.13%-3.85%-12.80%-17.43%-51.22%-18.00%9.67%41.84%-19.64%-77.50%
2018-26.64%-20.53%65.56%36.00%-25.00%66.67%8.24%8.70%3.00%74.76%22.22%-9.09%286.10%
2017-5.99%8.34%-30.41%12.61%-20.18%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of NVOS is 19, meaning it’s performing worse than 81% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of NVOS is 1919
Overall Rank
The Sharpe Ratio Rank of NVOS is 2525
Sharpe Ratio Rank
The Sortino Ratio Rank of NVOS is 3030
Sortino Ratio Rank
The Omega Ratio Rank of NVOS is 3030
Omega Ratio Rank
The Calmar Ratio Rank of NVOS is 22
Calmar Ratio Rank
The Martin Ratio Rank of NVOS is 88
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Novo Integrated Sciences, Inc. (NVOS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for NVOS, currently valued at -0.39, compared to the broader market-2.000.002.004.00-0.391.74
The chart of Sortino ratio for NVOS, currently valued at -0.03, compared to the broader market-4.00-2.000.002.004.006.00-0.032.35
The chart of Omega ratio for NVOS, currently valued at 1.00, compared to the broader market0.501.001.502.001.001.32
The chart of Calmar ratio for NVOS, currently valued at -0.92, compared to the broader market0.002.004.006.00-0.922.61
The chart of Martin ratio for NVOS, currently valued at -1.36, compared to the broader market0.0010.0020.0030.00-1.3610.66
NVOS
^GSPC

The current Novo Integrated Sciences, Inc. Sharpe ratio is -0.39. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Novo Integrated Sciences, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.00SeptemberOctoberNovemberDecember2025February
-0.39
1.77
NVOS (Novo Integrated Sciences, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Novo Integrated Sciences, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-99.98%
0
NVOS (Novo Integrated Sciences, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Novo Integrated Sciences, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Novo Integrated Sciences, Inc. was 99.99%, occurring on Nov 7, 2024. The portfolio has not yet recovered.

The current Novo Integrated Sciences, Inc. drawdown is 99.98%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.99%Nov 26, 20181414Nov 7, 2024
-69.63%Oct 5, 201773Feb 16, 201869Jun 26, 2018142
-38.43%Oct 3, 20182Oct 4, 201834Nov 23, 201836
-24.44%Jul 6, 20188Jul 17, 20189Jul 31, 201817
-22.77%Sep 27, 20173Sep 29, 20171Oct 2, 20174

Volatility

Volatility Chart

The current Novo Integrated Sciences, Inc. volatility is 47.26%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%50.00%100.00%150.00%SeptemberOctoberNovemberDecember2025February
47.26%
3.19%
NVOS (Novo Integrated Sciences, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Novo Integrated Sciences, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Novo Integrated Sciences, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab